ProShare Advisors LLC Has $1.03 Million Position in ICU Medical, Inc. (NASDAQ:ICUI)

ProShare Advisors LLC lifted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 45.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,613 shares of the medical instruments supplier's stock after acquiring an additional 2,081 shares during the quarter. ProShare Advisors LLC's holdings in ICU Medical were worth $1,026,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Arizona State Retirement System raised its position in shares of ICU Medical by 1.0% during the fourth quarter. Arizona State Retirement System now owns 6,730 shares of the medical instruments supplier's stock worth $1,044,000 after acquiring an additional 65 shares during the last quarter. Huntington National Bank raised its position in shares of ICU Medical by 6.2% during the fourth quarter. Huntington National Bank now owns 1,402 shares of the medical instruments supplier's stock worth $218,000 after acquiring an additional 82 shares during the last quarter. Equitable Trust Co. raised its position in shares of ICU Medical by 1.6% during the fourth quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier's stock worth $822,000 after acquiring an additional 84 shares during the last quarter. LPL Financial LLC increased its holdings in ICU Medical by 2.0% in the fourth quarter. LPL Financial LLC now owns 4,816 shares of the medical instruments supplier's stock valued at $747,000 after purchasing an additional 93 shares during the last quarter. Finally, Alliancebernstein L.P. increased its holdings in ICU Medical by 0.5% in the fourth quarter. Alliancebernstein L.P. now owns 26,107 shares of the medical instruments supplier's stock valued at $4,051,000 after purchasing an additional 136 shares during the last quarter. Institutional investors own 96.10% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts recently commented on ICUI shares. Needham & Company LLC reiterated a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Raymond James dropped their price objective on ICU Medical from $197.00 to $187.00 and set a "strong-buy" rating for the company in a report on Friday, May 9th. Wall Street Zen upgraded ICU Medical from a "hold" rating to a "buy" rating in a report on Sunday, May 18th. Finally, KeyCorp dropped their price objective on ICU Medical from $209.00 to $191.00 and set an "overweight" rating for the company in a report on Monday, April 21st. One investment analyst has rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, ICU Medical currently has a consensus rating of "Buy" and an average target price of $192.67.

Insider Buying and Selling

In related news, Director David C. Greenberg sold 1,942 shares of the stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $143.66, for a total transaction of $278,987.72. Following the sale, the director now owns 6,760 shares of the company's stock, valued at $971,141.60. This represents a 22.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, COO Christian B. Voigtlander sold 4,959 shares of the stock in a transaction that occurred on Thursday, May 22nd. The stock was sold at an average price of $130.03, for a total value of $644,818.77. Following the sale, the chief operating officer now directly owns 4,307 shares in the company, valued at $560,039.21. This represents a 53.52% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 26,167 shares of company stock worth $3,571,788. Corporate insiders own 1.50% of the company's stock.

ICU Medical Trading Up 1.1%

NASDAQ:ICUI traded up $1.41 on Tuesday, reaching $130.40. The company's stock had a trading volume of 99,832 shares, compared to its average volume of 276,804. ICU Medical, Inc. has a 1-year low of $100.91 and a 1-year high of $196.26. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The firm has a market cap of $3.21 billion, a PE ratio of -28.47 and a beta of 0.87. The business's 50-day moving average price is $139.22 and its two-hundred day moving average price is $152.03.

ICU Medical (NASDAQ:ICUI - Get Free Report) last posted its earnings results on Thursday, May 8th. The medical instruments supplier reported $1.72 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.23 by $0.49. The firm had revenue of $599.49 million during the quarter, compared to analysts' expectations of $574.15 million. ICU Medical had a positive return on equity of 5.05% and a negative net margin of 4.74%. The company's revenue was up 6.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.96 earnings per share. Equities research analysts anticipate that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.